Cadila Pharmaceuticals launches Vasograin Plus for treatment of migraines
Vasograin Plus represents a major advancement in the treatment of migraine
Vasograin Plus represents a major advancement in the treatment of migraine
A triple-action Formula for comprehensive respiratory relief
Allam was serving recently as the CEO at Public Investment Fund
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Subscribe To Our Newsletter & Stay Updated